- Home
- FTHM vs NEPH Comparison
FTHM vs NEPH Comparison
Compare FTHM & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- NEPH
- Stock Information
- Founded
- FTHM 2010
- NEPH 1997
- Country
- FTHM United States
- NEPH United States
- Employees
- FTHM N/A
- NEPH N/A
- Industry
- FTHM Real Estate
- NEPH Medical/Dental Instruments
- Sector
- FTHM Finance
- NEPH Health Care
- Exchange
- FTHM Nasdaq
- NEPH Nasdaq
- Market Cap
- FTHM 38.3M
- NEPH 45.3M
- IPO Year
- FTHM 2020
- NEPH 2004
- Fundamental
- Price
- FTHM $2.82
- NEPH $4.26
- Analyst Decision
- FTHM
- NEPH Strong Buy
- Analyst Count
- FTHM 0
- NEPH 2
- Target Price
- FTHM N/A
- NEPH $5.50
- AVG Volume (30 Days)
- FTHM 1.5M
- NEPH 44.2K
- Earning Date
- FTHM 11-06-2025
- NEPH 11-06-2025
- Dividend Yield
- FTHM N/A
- NEPH N/A
- EPS Growth
- FTHM N/A
- NEPH N/A
- EPS
- FTHM N/A
- NEPH 0.12
- Revenue
- FTHM $390,032,000.00
- NEPH $16,684,000.00
- Revenue This Year
- FTHM $25.22
- NEPH $24.38
- Revenue Next Year
- FTHM $16.19
- NEPH $10.16
- P/E Ratio
- FTHM N/A
- NEPH $35.74
- Revenue Growth
- FTHM 19.16
- NEPH 21.16
- 52 Week Low
- FTHM $0.65
- NEPH $1.36
- 52 Week High
- FTHM $3.37
- NEPH $5.00
- Technical
- Relative Strength Index (RSI)
- FTHM 70.20
- NEPH 55.77
- Support Level
- FTHM $1.80
- NEPH $3.62
- Resistance Level
- FTHM $2.98
- NEPH $4.59
- Average True Range (ATR)
- FTHM 0.45
- NEPH 0.37
- MACD
- FTHM 0.09
- NEPH 0.01
- Stochastic Oscillator
- FTHM 83.44
- NEPH 65.98
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.